loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 211928 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Strides Pharma Science

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ETHOSUXIMIDE (1)

    filter

    01 STRIDES PHARMA (1)

    filter

    01 CAPSULE;ORAL (1)

    filter

    01 250MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ethosuximide

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE;ORAL
    250MG
    ETHOSUXIMIDE
    USA
    211928
    2019-02-19
    RX
    Strides Pharma Science

    CPhI Worldwide, Milan

    Booth #5C33

    envelop Contact Supplier

    Looking for CTD TGA MCC DOSSIER APPLICATION 211928

    Looking for CTD TGA MCC DOSSIER APPLICATION 211928 1

    19

    Strides Pharma Science, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    One of their notable products is ETHOSUXIMIDE, with a corresponding application number 211928 and regulatory information .

    proudly manufactured in the

    approval since 2019-02-19

    Strides Pharma Science's ETHOSUXIMIDE CAPSULE;ORAL, medication with 250MG of ETHOSUXIMIDE.

    Post Enquiry
    POST ENQUIRY